Materias dentro de su búsqueda.
Mostrando 5,381 - 5,400 Resultados de 6,403 Para Buscar '"European Union"', tiempo de consulta: 0.24s Limitar resultados
  1. 5381
    “…BACKGROUND: The project "Antibiotic resistance in bacteria of animal origin – II" (ARBAO-II) was funded by the European Union (FAIR5-QLK2-2002-01146) for the period 2003–2005, with the aim to establish a continuous monitoring of antimicrobial susceptibility among veterinary laboratories in European countries based on validated and harmonised methodologies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002–2004
  2. 5382
    “…FUNDING: The Wellcome Trust, UK; University of the Witwatersrand, Medical Research Council, and Anglo American and De Beers Chairman's Fund, South Africa; the European Union; Andrew W Mellon Foundation, Henry J Kaiser Family Foundation, and National Institute on Aging, National Institutes of Health, USA.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study
  3. 5383
    por Schafheutle, Ellen I, Hassell, Karen
    Publicado 2009
    “…Recent changes in the registration routes onto the Register of Pharmacists of the Royal Pharmaceutical Society of Great Britain may have affected entries from overseas: reciprocal arrangements for pharmacists from Australia and New Zealand ended in June 2006; 10 new states joined the European Union in 2004 and a further two in 2007, allowing straightforward registration. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Internationally trained pharmacists in Great Britain: what do registration data tell us about their recruitment?
  4. 5384
    “…Data were analysed using mixed-effects model (MM), supplemented with pattern-mixture models (PMM), for the total sample and the US and European Union (EU) subgroups. RESULTS: Patients receiving sunitinib reported better scores in the primary end point, FKSI-DRS, across all patient populations (P<0.05), and in nine, five, and six end points in the total sample, in the US and EU groups respectively (P<0.05). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis
  5. 5385
    “…BACKGROUND: Hygiene inspections on passenger ships are important for the prevention of communicable diseases. The European Union (EU) countries conduct hygiene inspections on passenger ships in order to ensure that appropriate measures have been taken to eliminate potential sources of contamination which could lead to the spread of communicable diseases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Hygiene inspections on passenger ships in Europe - an overview
  6. 5386
    “…INTERPRETATION: The potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed. FUNDING: European Union, Wellcome Trust, and Wyeth.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
  7. 5387
    “…BACKGROUND: Within the European Union the use of growth promoting agents in animal production is prohibited. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Feasibility of a liver transcriptomics approach to assess bovine treatment with the prohormone dehydroepiandrosterone (DHEA)
  8. 5388
    “…BACKGROUND: Traumatic brain injury is a major cause of death and severe disability worldwide with 1,000,000 hospital admissions per annum throughout the European Union. Therapeutic hypothermia to reduce intracranial hypertension may improve patient outcome but key issues are length of hypothermia treatment and speed of re-warming. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    European society of intensive care medicine study of therapeutic hypothermia (32-35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial)
  9. 5389
    “…RESULTS: Spain ranked midway in the European Union in terms of the number of studies conducted on the HRQL of breast cancer patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Heath-related quality of life in Spanish breast cancer patients: a systematic review
  10. 5390
    “…BACKGROUND: In the third season of I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe), we undertook a multicentre case-control study based on sentinel practitioner surveillance networks in eight European Union (EU) member states to estimate 2010/11 influenza vaccine effectiveness (VE) against medically-attended influenza-like illness (ILI) laboratory-confirmed as influenza. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe
  11. 5391
    “…Within the framework of the EU (European Union) ENRIECO (ENvironmental Health RIsks in European Birth Cohorts) and EU OBELIX (OBesogenic Endocrine disrupting chemicals: LInking prenatal eXposure to the development of obesity later in life) projects, we examined the hypothesis that the combination of polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE) adversely affects birth weight. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Birth Weight and Prenatal Exposure to Polychlorinated Biphenyls (PCBs) and Dichlorodiphenyldichloroethylene (DDE): A Meta-analysis within 12 European Birth Cohorts
  12. 5392
    por Savill, Nicola, Bushe, Chris J
    Publicado 2012
    “…The BNFC has not yet been updated in line with the European Union (EU) Directive on methylphenidate; it does not include any contraindications for atomoxetine but describes contraindications for methylphenidate that are no longer in the SPC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?
  13. 5393
    “…RESULTS: We identified 32 towns in which ischemic heart disease mortality was half the national rate and four times lower than the European Union rate, situated in lightly populated provinces spread across the northern half of Spain, and revealed a surprising pattern of geographic aggegation for 23 of the 32 towns. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Towns with extremely low mortality due to ischemic heart disease in Spain
  14. 5394
    “…Furthermore, being a native of this country, the European Union or Central/South America represents a greater likelihood of use than being African or Asian. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors determining family planning in Catalonia. Sources of inequity
  15. 5395
    “…Our results confirm that comparison of reported incidence between countries can be grossly misleading, even within the European Union. Because sero-incidence includes asymptomatic infections, it is not a direct measure of burden of illness. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases
  16. 5396
    “…CONCLUSIONS: Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
  17. 5397
    “…The trial is registered with the French Agency of Pharmaceutical Products (AFSSAPS) under the number 2008-A0277-48, the European Union Drug Regulating Authorities Clinical Trials. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial
  18. 5398
    “…The Standard care versus Celecoxib Outcome Trial (SCOT) compares the cardiovascular safety of celecoxib with traditional NSAID therapy in the setting of the European Union healthcare system. METHODS AND ANALYSIS: SCOT is a large streamlined safety study conducted in Scotland, England, Denmark and the Netherlands using the Prospective Randomised Open Blinded Endpoint design. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
  19. 5399
    “…The present assessment is based on ICER values resulting from this analysis, which are lower than the thresholds proposed by health care authorities in other European Union countries. These benefits are driven by the effectiveness of escitalopram, which result in an improved health-related quality of life, a higher probability of sustained remission, and better utilization of health care resources. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
  20. 5400
    “…BACKGROUND: Although most countries in the European Union are richer and healthier than ever, health inequalities remain an important public health challenge. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Does neighbourhood social capital aid in levelling the social gradient in the health and well-being of children and adolescents? A literature review
Herramientas de búsqueda: RSS